BIOMAT Database Logo BIOMAT Database Logo

[Principles of prevention and treatment of EPH gestosis]. 1992

G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur

UI MeSH Term Description Entries
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D011225 Pre-Eclampsia A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease. Toxemias, Pregnancy,EPH Complex,EPH Gestosis,EPH Toxemias,Edema-Proteinuria-Hypertension Gestosis,Gestosis, EPH,Hypertension-Edema-Proteinuria Gestosis,Preeclampsia,Preeclampsia Eclampsia 1,Pregnancy Toxemias,Proteinuria-Edema-Hypertension Gestosis,Toxemia Of Pregnancy,1, Preeclampsia Eclampsia,1s, Preeclampsia Eclampsia,EPH Toxemia,Eclampsia 1, Preeclampsia,Eclampsia 1s, Preeclampsia,Edema Proteinuria Hypertension Gestosis,Gestosis, Edema-Proteinuria-Hypertension,Gestosis, Hypertension-Edema-Proteinuria,Gestosis, Proteinuria-Edema-Hypertension,Hypertension Edema Proteinuria Gestosis,Of Pregnancies, Toxemia,Of Pregnancy, Toxemia,Pre Eclampsia,Preeclampsia Eclampsia 1s,Pregnancies, Toxemia Of,Pregnancy Toxemia,Pregnancy, Toxemia Of,Proteinuria Edema Hypertension Gestosis,Toxemia Of Pregnancies,Toxemia, EPH,Toxemia, Pregnancy,Toxemias, EPH
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004903 Erythrocyte Aggregation The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation. Erythrocyte Aggregation, Intravascular,Agglutination, Intravascular,Intravascular Agglutination,Intravascular Erythrocyte Aggregation,Rouleaux Formation, Erythrocyte,Agglutinations, Intravascular,Aggregation, Erythrocyte,Aggregation, Intravascular Erythrocyte,Aggregations, Erythrocyte,Aggregations, Intravascular Erythrocyte,Erythrocyte Aggregations,Erythrocyte Aggregations, Intravascular,Erythrocyte Rouleaux Formation,Erythrocyte Rouleaux Formations,Formation, Erythrocyte Rouleaux,Formations, Erythrocyte Rouleaux,Intravascular Agglutinations,Intravascular Erythrocyte Aggregations,Rouleaux Formations, Erythrocyte
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[Treatment and prevention of EPH-gestosis].
January 1978, Pielegniarka i polozna,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[Our principles concerning the prevention of EPH gestosis (author's transl)].
April 1976, Ceskoslovenska gynekologie,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[Medical treatment of EPH-gestosis].
January 1977, Annali di ostetricia, ginecologia, medicina perinatale,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[EPH-gestosis].
January 1978, Jugoslavenska ginekologija i opstetricija,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[EPH gestosis. Guidelines for diagnosis, prevention and therapy].
September 1976, Fortschritte der Medizin,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[Early diagnosis, prevention and basic pathology of EPH gestosis].
July 1985, Wiener medizinische Wochenschrift (1946),
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[Immunocomplexes and EPH-gestosis].
December 1984, Ceskoslovenska gynekologie,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[New possibilities in the prevention and therapy of EPH gestosis].
May 1990, Ceskoslovenska gynekologie,
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
[EPH (edema-proteinuria-hypertension)-gestosis. Ophthalmoscopy and prevention of eclampsia].
April 1972, Munchener medizinische Wochenschrift (1950),
G M Savel'eva, and R I Shalina, and G D Dzhivelegova, and A Z Kashezheva, and D Gandur
Estimation of gestosis of pregnancy (EPH-gestosis).
January 1973, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!